Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P190002/S051

Saluda Medical Evoke SCS System

Saluda Medical Pty, Ltd. · Decision date Oct 15, 2026

MEDTECHLEDGER EXPLANATIONP190002/S051

What did the FDA decide?

The FDA record lists PMA supplement P190002/S051 for Saluda Medical's Evoke spinal cord stimulation system under a 30-Day Notice. The stated change: "change the formulation of the adhesive used on the Tyvek packaging of the paddle lead kit." The supplement reason is "Process Change - Manufacturer/Sterilizer/Packager/Supplier," and the device category is a totally implanted spinal-cord stimulator for pain relief (product code LGW, Neurology).

Because S051 carries the P190002 number, it is a supplement to that original PMA rather than a separate approval of the system. The record does not identify the prior or new adhesive formulation, the supplier, the sterilization route, or supporting data, and the reported purpose is not independent proof of safety or clinical effectiveness. The database shows decision code OK30 dated 2026-10-15.

FDA approval order statement

change the formulation of the adhesive used on the Tyvek packaging of the paddle lead kit
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Neurology
Decision date
Oct 15, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P190002/S051
Regulatory pathway
PMA supplement
Product code
LGW
Decision code
OK30
Decision date
Oct 15, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stimulator, spinal-cord, totally implanted for pain relief.

Product code
LGW
FDA device class
3

For the original device and its historical approval scope, see PMA P190002. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P190002 · Original PMA

    Saluda Medical Evoke SCS System

  2. P190002/S051 received

    Application receipt date recorded by FDA.

  3. P190002/S051 · FDA decision

    30-Day Notice

  4. P190002/S052 · Related supplement

    Saluda Medical Evoke SCS System

Timeline entries are records held by MedtechLedger for P190002. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P190002

Product / regulatory recordCompanyPathwayDecision dateSource
Saluda Medical Pty, Ltd.PMA approvalFeb 28, 2022FDA
Saluda Medical Pty, Ltd.PMA supplementOct 16, 2026FDA

Explore the linked device profile

Other records with product code LGW

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Saluda Medical Pty, Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Level 1, 407 Pacific Hwy., Atarmon, NSW 2064

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records